Soft NMs |
Polymeric NMs |
PLGA-BSA |
Promote osteogenic, impair adipogenic differentiation |
— |
Suggested |
p38 mitogen-activated protein kinase pathway |
MSCs |
106
|
Hard NMs |
Ceramic NMs |
Mono-SMBGs |
No |
— |
— |
— |
MSCs, ADSCs |
114
|
HAP NPs (20 nm) |
Promote osteogenic differentiation |
— |
— |
— |
MSCs |
116
|
Nanosilicates |
Promote osteogenic differentiation |
— |
— |
— |
ADSCs |
117
|
|
Carbon NMs |
SWCNTs |
Promote adipogenic, osteogenic, chondrogenic |
— |
— |
— |
MSCs |
121
|
Hard NMs |
Carbon NMs |
SWCNTs |
Promote neurogenic differentiation |
— |
— |
— |
MSCs |
122
|
Neurogenic differentiation |
— |
— |
Neurotrophin signaling pathway |
MSCs |
123
|
MWCNTs |
Inhibit osteogenic, adipogenic differentiation |
No |
— |
Smad-dependent BMP signaling pathway |
PC12 cells |
124
|
rGO nanosheets |
Promote osteogenic differentiation |
— |
— |
— |
MSCs |
125
|
Hard NMs |
Carbon NMs |
GO (hundreds of nanometers to several mircometers) |
Enhance dopamine neural differentiation |
— |
— |
— |
Mouse embryonic stem cells (ESCs) |
132
|
GO (400 nm) |
Enhance neurogenesis |
— |
— |
— |
Human fetal neural stem cells (hfNSCs) |
133
|
Hard NMs |
Carbon NMs |
Nanodiamonds |
No |
— |
— |
— |
Embryonal |
139
|
Metal/metal oxide NMs |
Citrate-AuNPs |
Promote osteogenic and inhibit adipogenic differentiation |
— |
— |
— |
Human fetal neural stem cells (hfNSCs) |
145
|
Chitosan-AuNPs |
Promote osteogenic differentiation |
— |
Suggested |
P38 mitogen-activated protein kinase |
MSCs |
146
|
Citrate-AuNPs (15–100 nm) |
Promote osteogenic differentiation |
— |
— |
Wnt/β-catenin |
ADSCs |
147
|
Hard NMs |
Metal/metal oxide NMs |
BSA-AuNPs (70, 100 nm) |
Promote osteogenic differentiation |
— |
Suggested |
— |
MSCs |
148
|
BSA-AuNPs (40 nm) |
Inhibit osteogenic differentiation |
— |
Suggested |
— |
MSCs |
148
|
BSA coated gold nanostars (40–110 nm) |
No |
— |
Suggested |
— |
MSCs |
148
|
BSA coated gold nanorods (70 nm) |
Promote osteogenic differentiation |
— |
Suggested |
— |
MSCs |
148
|
Hard NMs |
Metal/metal oxide NMs |
PEG-AuNPs (40 nm) |
Promote osteogenic differentiation |
— |
Suggested |
— |
MSCs |
149
|
PEG-AuNPs (4 nm) |
Inhibit osteogenic and promote adipogenic differentiation |
Suggested |
Suggested |
— |
MSCs |
149
|
AuNP–NH2 (21 nm), AuNP–OH (12 nm) |
No |
— |
— |
— |
MSCs |
150
|
Hard NMs |
Metal/metal oxide NMs |
AuNP–COOH (17 nm) |
Inhibit osteogenic differentiation |
— |
— |
— |
MSCs |
150
|
l(d)-PAV-AuNPs, (5 nm) |
Enhance osteogenic differentiation |
— |
Suggested |
P38 MAPK |
MSCs |
151
|
AgNPs |
Promote osteogenic differentiation |
— |
Suggested |
— |
Urine-derived stem cells |
156
|
PVP-AgNPs |
No |
— |
— |
— |
MSCs |
157
|
ZnO NPs |
Promote osteogenic differentiation |
— |
— |
— |
MSCs |
165
|
Hard NMs |
Metal/metal oxide NMs |
TiO2 NPs |
Promote neural differentiation |
— |
— |
— |
NSCs |
167
|
TiO2–COOH NRs |
No |
— |
— |
— |
MSCs |
169
|
CuO NPs |
No |
— |
— |
— |
MSCs |
170
|
CeO2 NPs (40, 60 nm) |
Accelerate adipogenic transdifferentiation |
— |
— |
— |
Osteoblasts |
171
|